期刊文献+

伽玛刀治疗颅内转移瘤较手术切除肿瘤的疗效分析

Effect of gamma knife radiosurgery in the treatment of intracranial metastatic tumors compare with surgical resection of tumors
下载PDF
导出
摘要 目的 分析伽玛刀治疗颅内转移瘤的临床疗效.方法 选取2011年1~12月本科因肺癌脑转移头部行伽玛刀患者68例(实验组),同时选取同期手术治疗肺癌脑转移瘤的患者45例(对照组),所有患者均结合相关化疗.分别于治疗前后行MRI、DWI及MRS(磁共振波谱分析)扫描,对比两组患者治疗前及治疗后3个月的MRI及MRS相关指标.同时在两组患者治疗后3个月、6个月和12个月进行头颅MRI平扫随访,对比两组患者的临床疗效和生存率.结果 两组患者治疗3月后nCho、Cho/Cr,Cho/NAA及Cho/cNAA均显著较术前降低,nCr均显著较术前升高,ADC值及rADC比值均显著较术前升高,P〈0.05;实验组治疗3月后nCho、Cho/Cr,Cho/NAA及Cho/cNAA均显著较对照组降低,nCr均显著较对照组升高,ADC值及rADC比值均显著较对照组升高,P〈0.05.实验组治疗后3月的临床有效率显著高于对照组,P〈0.05;实验组治疗后6月的临床有效率与对照组无显著差异,P〉0.05;实验组治疗后12月的临床有效率显著高于对照组,P〈0.05.实验组患者治疗后3个月生存率为100%(68/68),6个月生存率为83.82%(57/68),12个月生存率为61.76%(42/68);对照组治疗后3个月生存率为100%(45/45),6个月生存率为73.33%(33/45),12个月生存率为53.33%(24/45).结论 采取伽马刀治疗颅内转移瘤的临床疗效显著优于手术切除. Objective To analysis the clinical curative effect of gamma knife treatment of intracranial metastases.Selection.Methods Between January 2011 and December 2011,our department from 68 patients with brain metastases from lung cancer lines of gamma knife head(experimental group),and in the same period surgical treatment of patients with brain metastases of lung cancer 45 cases(control group),all patients were combined with chemotherapy.MRI,DWI and MRS can on line before and after treatment respectively(resonance spectroscopy analysis) scanning,compared two groups of patients before and after treatment for 3 months of MRI and MRS related indicators.At the same time in the two groups of patients after treatment for 3 months,6 months and 12 months follow-up on cranial magnetic resonance imaging(MRI) scan,compared two groups of clinical curative effect and survival rate of patients.Results Two groups of patients after march nCho,Cho/Cr,Cho/NAA and Cho/cNAA were significantly reduced compared with preoperative,nCr were significantly higher than preoperative,ADC values and the rADC ratio were significantly higher than preoperative,P〈0.05;Group 3 months after treatment nCho,Cho/Cr,Cho/NAA and Cho/cNAA were significantly reduced than the control group,nCr were significantly higher than the control group,the ADC values and rADC ratio were significantly higher than the control group,P〈 0.05).In march of the experimental group after treatment of clinical effectiveness is significantly higher than the control group,P〈 0.05;The experimental group after treatment the clinical efficient and the control group had no significant difference in June,P〉0.05;The experimental group in December after treatment of clinical effectiveness is significantly higher than the control group,P〈 0.05.Group 3 months after treatment in patients with survival rate was 100%(68/68),the survival rate was 83.82%(57/68) at 6 months,12 months survival rate was 61.76%(42/68);The control group after treatment for 3 months survival rate was 100%(45/45),the survival rate was 73.33%(33/45) at 6 months,12 months survival rate was 53.33%(24/45).Conclusion The clinical effects of Gamma knife could be better than surgery for the removing of intracranial metastases.
作者 王永才 WANG Yong cai(Department of Radiotherapy ,the 202nd Hospital of PLA , Shenyang, Liaoning 110000, China)
出处 《检验医学与临床》 CAS 2017年第A01期163-166,共4页 Laboratory Medicine and Clinic
关键词 伽玛刀 颅内转移瘤 手术切除 gamma knife intracranial metastases resection
  • 相关文献

参考文献5

二级参考文献40

  • 1王业忠,刘祺,彭心宇.脑转移瘤治疗的研究进展[J].中华神经外科疾病研究杂志,2005,4(6):569-570. 被引量:1
  • 2Belderbos J S,De Jaeger K, Heem sbergen W D,et al. Firs resuits of a phase Ⅰ/Ⅱ dose escalation trial in non-small cell lung cancer using three dimensional conformal radiothcrapy[J]. Radiother Oncol,2003,66(2) : 119-126.
  • 3Parkin D M. Global cancer statistics in the year 2000[J]. Lancet Oncol, 9001, 2(9):533-543.
  • 4Jonesa B,Dalea R G,Deehanb C, et al. The role of biologically effective dose (BED) in clinical oncology[J].Clinical Oncology, 2001,13(9):71-78.
  • 5Cox J D. Stetz J, Pajak T F. Toxicity criteria of the radiation therapy oncology group (TROG) and the European organization for research and treatment of cancer ( EORTC)[J].Int J Radiat Oncol Biol Phys,1995.31:1341-1346.
  • 6Kong F M. Zhao L, Haymanj A. The roleof radiation therapy in thoracic tumorsr[J].Hematol Oncol Clin North Am.2006 20(2):368-400.
  • 7Martel M K. Advanced radiation treatment planning and delivcry approaches for treatment of lung cancer[J].Hematol Oncol Clin North Am, 2004,18(1) :231-213.
  • 8Fubunka M, Yano S, Graccone G, et al. Multi institutional ran dora ized phase Ⅱ trial of Gefitinib for previously treated patients with advanced non-small cell lung cancer[J]. Clin Oncology.2003,21(12) :2237.
  • 9LoRusso P M, Herbst R S, Rischin D. et al. Improvements in quality of life and disease-related symptoms in phase Ⅰ trials of the selective oral epidermal growth factor receptor lyrosine ki nase inhibitor ZD1839 in non small cell lung cancer and other sol id tumors[J].Clin Cancer Res,2003,9(6):2040-2048.
  • 10张国荣 王宏伟 朱利峰 等.肺癌多发脑转移的选择性治疗.内蒙古医学院学报,2009,31(3):302-304.

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部